Skip to main content

Table 5 Suspected drug, ADR, outcome and causality

From: Incidence of adverse reaction of drugs used in COVID-19 management: a retrospective, observational study

Suspected drugs

Patient on treatment

ADR

Outcome

Causalitya

Recovered

Recovering

Probable

Possible

Atazanavir

167

88 (52.7%)

57

29

57

29

Chloroquine

19

7 (36.8%)

7

0

0

7

Lopinavir/ritonavir

214

78 (36.4%)

75

3

18

60

Ribavirin

7

1 (14.3%)

1

0

1

0

Hydroxychloroquine

1035

118 (11.4%)

107

11

22

96

Interferon beta-1b

91

3 (4.4%)

3

0

0

3

Tocilizumab

8

0

0

0

0

0

Favipiravir

6

0

0

0

0

0

  1. ADR is reported as n (%), where % is calculated by taking ADR/patient on treatment
  2. aNo ADR cases were classified as certain